Lorsumo 8 mg/4 mg Tablet MR
By Lorsumo
Rx
10 Tablet MR in a Strip

Composition
Lornoxicam(8mg) + Thiocolchicoside(4mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
October, 2025

liver
When using Lorsumo 8 mg/4 mg Tablet MR, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment for this medication. It is advisable to consult your doctor before taking Lorsumo 8 mg/4 mg Tablet MR to ensure proper management and safety.

kidney
Lorsumo 8 mg/4 mg Tablet MR is considered safe for patients with kidney disease. Data suggests dose adjustment may not be necessary. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while taking Lorsumo 8 mg/4 mg Tablet MR. It is best to avoid alcohol when using this medication.

driving
Lorsumo 8 mg/4 mg Tablet MR may cause side effects impacting driving. Take caution while driving.

pregnancy
Lorsumo 8 mg/4 mg Tablet MR is not safe during pregnancy due to risks to the developing baby. Consult your doctor before use, as it may be advised only in critical situations where benefits outweigh risks.

breastfeeding
It is better to consult your doctor before using Lorsumo 8 mg/4 mg Tablet MR during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹140
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025